M&A | Partnerships

November 29, 2021

Bone Therapeutics Partners on Global ALLOB Rights

Bone Therapeutics Partners on Global ALLOB Rights
Link Health will have global rights for development, manufacturing and commercialization of ALLOB allogeneic bone cell therapy.
November 9, 2021

Graftys Acquires Biologics4Life

Graftys Acquires Biologics4Life
Biologics4Life is developing a injectable synthetic bone graft materials, complementing Graftys' resorbable calcium phosphate cement.
October 29, 2021

Bioventus Completes the Acquisition of Misonix

Bioventus Completes the Acquisition of Misonix
The combined company will operate as a pure-play regenerative medicine and orthopedics company, serving hospital, ASC and office care settings.
August 17, 2021

Royal Biologics Partners with Vilex for Lower Extremities

Royal Biologics Partners with Vilex for Lower Extremities
Vilex will market and distribute Royal Biologics' portfolio of Autologous and Live Cellular therapies for lower extremity orthopedic procedures.
July 30, 2021

Bioventus to Acquire Misonix, Enhance Surgical Solutions

Bioventus to Acquire Misonix, Enhance Surgical Solutions
The merger will create a company positioned with products and specialized salesforces serving hospital, ambulatory surgical center and office care settings.
December 29, 2020

Collagen Matrix Acquires Resorbable Synthetic Bone Grafts

Collagen Matrix Acquires Resorbable Synthetic Bone Grafts
The transaction includes GUIDOR bone graft substitutes known as easy-graft and calc-i-oss, and builds on the company's strategy to expand its technologies.